Julian Harrison
Stock Analyst at BTIG
(4.98)
# 63
Out of 4,655 analysts
533
Total ratings
56.3%
Success rate
53.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Julian Harrison
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TVRD Tvardi Therapeutics | Maintained: Buy | $15 → $5 | $1.77 | +182.49% | 8 | Aug 17, 2026 | |
| OTLK Outlook Therapeutics | Reiterated: Buy | $4 | $1.10 | +263.64% | 22 | Aug 17, 2026 | |
| NKTR Nektar Therapeutics | Maintained: Buy | $178 | $76.03 | +134.12% | 19 | Aug 14, 2026 | |
| LQDA Liquidia | Maintained: Buy | $109 → $111 | $78.79 | +40.88% | 47 | Aug 12, 2026 | |
| CNTB Connect Biopharma Holdings | Maintained: Buy | $10 | $2.33 | +329.18% | 7 | Aug 12, 2026 | |
| SYRE Spyre Therapeutics | Rated: Buy | $112 → $132 | $104.09 | +26.81% | 24 | Aug 11, 2026 | |
| MAZE Maze Therapeutics | Maintained: Buy | $46 | $27.53 | +67.09% | 7 | Aug 11, 2026 | |
| ORKA Oruka Therapeutics | Maintained: Buy | $151 | $107.40 | +40.60% | 13 | Aug 10, 2026 | |
| MLTX MoonLake Immunotherapeutics | Maintained: Buy | $30 | $17.23 | +74.11% | 33 | Aug 10, 2026 | |
| JBIO Jade Biosciences | Maintained: Buy | $74 → $77 | $23.21 | +231.75% | 19 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $0.8932 | +347.83% | 14 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $58 | $19.55 | +196.68% | 11 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $44 | $8.68 | +407.20% | 11 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $14.39 | +38.99% | 10 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 | $20.81 | +101.83% | 5 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $58 | $42.77 | +35.61% | 8 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $38 → $39 | $19.60 | +98.98% | 25 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $150 → $175 | $125.52 | +39.42% | 15 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $16.92 | - | 16 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $137 | $134.55 | +1.82% | 27 | Jun 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $6 | $4.70 | +27.66% | 16 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1 | $0.3029 | +230.14% | 14 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $511.72 | - | 19 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $3.97 | +328.21% | 8 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $61 | $22.88 | +166.61% | 20 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $82 | $152.01 | -46.06% | 32 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $0.8028 | n/a | 11 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $162 | $51.80 | n/a | 8 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $11.20 | n/a | 18 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $56.98 | n/a | 4 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $8 | $5.84 | n/a | 16 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 | $7.75 | n/a | 13 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $150 → $50 | $0.24 | n/a | 5 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4 | $0.000001 | n/a | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $34.02 | n/a | 3 | Apr 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 | $1.52 | n/a | 2 | Apr 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $51 | $1.07 | n/a | 1 | Apr 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $60 | $4.71 | n/a | 1 | Dec 9, 2020 |
Tvardi Therapeutics
Aug 17, 2026
Maintained: Buy
Price Target: $15 → $5
Current: $1.77
Upside: +182.49%
Outlook Therapeutics
Aug 17, 2026
Reiterated: Buy
Price Target: $4
Current: $1.10
Upside: +263.64%
Nektar Therapeutics
Aug 14, 2026
Maintained: Buy
Price Target: $178
Current: $76.03
Upside: +134.12%
Liquidia
Aug 12, 2026
Maintained: Buy
Price Target: $109 → $111
Current: $78.79
Upside: +40.88%
Connect Biopharma Holdings
Aug 12, 2026
Maintained: Buy
Price Target: $10
Current: $2.33
Upside: +329.18%
Spyre Therapeutics
Aug 11, 2026
Rated: Buy
Price Target: $112 → $132
Current: $104.09
Upside: +26.81%
Maze Therapeutics
Aug 11, 2026
Maintained: Buy
Price Target: $46
Current: $27.53
Upside: +67.09%
Oruka Therapeutics
Aug 10, 2026
Maintained: Buy
Price Target: $151
Current: $107.40
Upside: +40.60%
MoonLake Immunotherapeutics
Aug 10, 2026
Maintained: Buy
Price Target: $30
Current: $17.23
Upside: +74.11%
Jade Biosciences
Aug 10, 2026
Maintained: Buy
Price Target: $74 → $77
Current: $23.21
Upside: +231.75%
Aug 6, 2026
Reiterated: Buy
Price Target: $4
Current: $0.8932
Upside: +347.83%
Aug 6, 2026
Maintained: Buy
Price Target: $58
Current: $19.55
Upside: +196.68%
Aug 6, 2026
Maintained: Buy
Price Target: $44
Current: $8.68
Upside: +407.20%
Aug 6, 2026
Maintained: Buy
Price Target: $20
Current: $14.39
Upside: +38.99%
Aug 5, 2026
Maintained: Buy
Price Target: $42
Current: $20.81
Upside: +101.83%
Aug 3, 2026
Initiated Coverage: Buy
Price Target: $58
Current: $42.77
Upside: +35.61%
Jul 29, 2026
Rated: Buy
Price Target: $38 → $39
Current: $19.60
Upside: +98.98%
Jun 30, 2026
Rated: Buy
Price Target: $150 → $175
Current: $125.52
Upside: +39.42%
Jun 29, 2026
Downgraded: Hold
Price Target: n/a
Current: $16.92
Upside: -
Jun 19, 2026
Reiterated: Buy
Price Target: $137
Current: $134.55
Upside: +1.82%
Jun 2, 2026
Maintained: Buy
Price Target: $5 → $6
Current: $4.70
Upside: +27.66%
Mar 19, 2026
Maintained: Buy
Price Target: $1
Current: $0.3029
Upside: +230.14%
Feb 25, 2026
Maintained: Hold
Price Target: n/a
Current: $511.72
Upside: -
Feb 20, 2026
Reiterated: Buy
Price Target: $17
Current: $3.97
Upside: +328.21%
Nov 4, 2025
Reiterated: Buy
Price Target: $61
Current: $22.88
Upside: +166.61%
Nov 3, 2025
Maintained: Buy
Price Target: $82
Current: $152.01
Upside: -46.06%
Mar 31, 2025
Maintained: Buy
Price Target: $14
Current: $0.8028
Upside: n/a
Mar 17, 2025
Maintained: Buy
Price Target: $162
Current: $51.80
Upside: n/a
Dec 12, 2024
Downgraded: Hold
Price Target: n/a
Current: $11.20
Upside: n/a
Dec 2, 2024
Downgraded: Hold
Price Target: n/a
Current: $56.98
Upside: n/a
Nov 18, 2024
Upgraded: Buy
Price Target: $8
Current: $5.84
Upside: n/a
Nov 13, 2024
Maintained: Buy
Price Target: $24
Current: $7.75
Upside: n/a
Nov 9, 2023
Rated: Buy
Price Target: $150 → $50
Current: $0.24
Upside: n/a
May 3, 2022
Initiated Coverage: Buy
Price Target: $4
Current: $0.000001
Upside: n/a
Apr 28, 2021
Maintained: Buy
Price Target: $12
Current: $34.02
Upside: n/a
Apr 27, 2021
Maintained: Buy
Price Target: $29
Current: $1.52
Upside: n/a
Apr 20, 2021
Initiated Coverage: Buy
Price Target: $51
Current: $1.07
Upside: n/a
Dec 9, 2020
Initiated Coverage: Buy
Price Target: $60
Current: $4.71
Upside: n/a